510(k) device
CIRRUS HD-OCT Model 6000
Carl Zeiss Meditec, Inc. · Tomography, Optical Coherence (OBO, Class II) · First FDA decision May 5, 2009, newest May 17, 2024GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
510(k) pathway
Device trials
10
Naming "CIRRUS HD-OCT"
MAUDE reports
2
Brand "CIRRUS HD-OCT", since 2015
PubMed studies
533
Mentioning "CIRRUS HD-OCT"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 6 of 6 decisions filed under this name.
K233933 · Decided May 17, 2024 · 155 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- CIRRUS HD-OCT510(k)
K222200 · Decided Apr 13, 2023 · 262 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- CIRRUS HD-OCT510(k)
K181534 · Decided Feb 15, 2019 · 249 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- CIRRUS HD-OCT510(k)
K150977 · Decided Sep 1, 2015 · 141 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K111157 · Decided Jan 19, 2012 · 269 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K083291 · Decided May 5, 2009 · 179 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CIRRUS HD-OCT", any status and sponsor, newest update first.
- (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000Pivotal-lookingRecruiting
Carl Zeiss Meditec-Dublin CoCeNot on our public-company list
NCT07680244 · 400 participants (planned) · Start May 23, 2025 · Primary completion Aug 2026
Device: PathFinder 1.0 on CIRRUS HD-OCT · For: Epiretinal Membrane; Dry Age Related Macular Degeneration; Macular Abnormalities and 7 more
Sites: Tucson, Arizona; Mountain View, California; San Francisco, California · 6 sites in all
Okan UniversityAcademic, hospital or other
NCT06674369 · 15 participants · Start Aug 28, 2022 · Primary completion Oct 18, 2022
Device: Peli prism for hemianopia · For: Homonymous Hemianopsia
Sites: Istanbul, Turkey (Türkiye)
Topcon CorporationNot on our public-company list
NCT04701931 · 135 participants · Start Jan 7, 2021 · Primary completion Nov 9, 2022
Device: Maestro2 OCTA; Cirrus HD-OCT 5000 and 1 more · For: Retina Condition Followed by Fluorescein Angiography Imaging
Sites: Santa Ana, California; Augusta, Georgia
Topcon CorporationNot on our public-company list
NCT04201340 · 211 participants · Start Dec 11, 2019 · Primary completion Jul 28, 2022
Device: DRI OCT Triton with SS-OCT Angio software; Cirrus HD-OCT 5000 and 1 more · For: Fluorescein Angiography Imaging
Sites: Augusta, Georgia
Semmelweis UniversityAcademic, hospital or other
NCT03590899 · 39 participants · Start Feb 1, 2017 · Primary completion Nov 20, 2018
Device: Optical coherence tomography angiography (Zeiss Cirrus HD OCT 5000 AngioPlex) · For: Healthy
Sites: Budapest, Hungary
London Vision ClinicAcademic, hospital or other
NCT03473847 · 242 participants (planned) · Start Sep 1, 2022 · Primary completion Dec 1, 2023
Device: ArcScan Insight 100 very high-frequency digital ultrasound; Carl Zeiss Meditec Cirrus HD OCT 5000 and 2 more · For: Corneal Thickness Measurement; Epithelial Thickness Measurement; LASIK Flap Thickness Measurement and 1 more
Sites: London, United Kingdom
National University of MalaysiaAcademic, hospital or other
NCT04215445 · 90 participants (planned) · Start Dec 1, 2019 · Primary completion May 2020
Device: OCT-A · For: Diabetic Retinopathy; Chronic Kidney Diseases; Diabetes Mellitus
Sites: Kuala Lumpur, Malaysia
Glostrup University Hospital, CopenhagenAcademic, hospital or other
NCT00873106 · 20 participants · Start Feb 2009 · Primary completion Mar 2010
Device: Optical coherence tomography · For: Healthy; Diabetic Maculopathy
Sites: Glostrup Municipality, Denmark
Yonsei UniversityAcademic, hospital or other
NCT00926549 · 300 participants (planned) · Start May 2009 · Primary completion Sep 2009
Device: Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG) · For: Healthy; Myopia; Hypermetropia
Sites: Seoul, South Korea
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser SurgeryAcademic, hospital or other
NCT00643422 · 16 participants (planned)
Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG · For: Healthy
Sites: Vienna, Austria
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CIRRUS HD-OCT", and for the whole product code for context.
This brand
2 reports: 2 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
- ZEISS CIRRUS HD-OCT 4000 RETINA TOMOGRAPHERMalfunction
MW5159680 · Received Sep 17, 2024 · Event dated Sep 11, 2024
Device type: Tomography, Optical Coherence (OBO)
Patient problem as coded: Insufficient Information
- CIRRUS HD-OCT 6000Malfunction
2918630-2023-00001 · Received Apr 4, 2023 · Event dated Mar 16, 2023
Device type: Tomography, Optical Coherence (OBO)
Device problem as coded: Unintended Electrical Shock
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- CIRRUS HD-OCT, Models 5000 AngioPlex and 6000 AngioPlexOpen, Classified
Z-0723-2022 · Started Jan 14, 2022
Reason given: Optic nerve head angiography scan to be turned off due to its distribution without pre-market clearance.
Cause as FDA categorized it: No Marketing Application · Device type: Tomography, Optical Coherence (OBO)
- Chassis Label - "CIRRUS HD-OCT Rx-Only" Product Label Exterior RX - "CIRRUS HD-OCT Model 6000"Open, Classified
Z-2227-2021 · Started Jul 8, 2021
Reason given: Due to failure to acquire pre-market clearance for its high resolution tomographic/biomicroscope imaging device (Model 6000) prior to commercializing the device.
Cause as FDA categorized it: No Marketing Application · Device type: Tomography, Optical Coherence (OBO)
Z-2126-2011 · Started Mar 10, 2011 · Posted by FDA May 2, 2011
Reason given: A software defect exists in versions 5.0.0 and 5.1.0 where when following a specific workflow, exam data may be saved under the name of the first patient
Cause as FDA categorized it: Software design · Device type: Tomography, Optical Coherence (OBO)
Z-2127-2011 · Started Mar 10, 2011 · Posted by FDA May 2, 2011
Reason given: A software defect exists in versions 5.0.0 and 5.1.0 where when following a specific workflow, exam data may be saved under the name of the first patient
Cause as FDA categorized it: Software design · Device type: Tomography, Optical Coherence (OBO)
Published research
The most relevant PubMed records for "CIRRUS HD-OCT"[tiab]. The summary above synthesizes these.
- Factors Affecting Cirrus-HD OCT Optic Disc Scan Quality: A Review with Case Examples.
Hardin JS, Taibbi G, Nelson SC, et al. · J Ophthalmol · 2015Review
- Accuracy of Cirrus HD-OCT and Topcon SP-3000P for measuring central corneal thickness.
Calvo-Sanz JA, Ruiz-Alcocer J, Sánchez-Tena MA · J Optom · 2018
- Photobleaching by Spectralis Fixation Target.
Tomasso L, Benatti L, Carnevali A, et al. · JAMA Ophthalmol · 2016
- Multimodal ocular evaluation in hemodialysis patients.
Mayali H, Altinisik M, Sarigul C, et al. · Int Ophthalmol · 2021
- Comparison of macular thickness between Cirrus HD-OCT and Stratus OCT.
Kakinoki M, Sawada O, Sawada T, et al. · Ophthalmic Surg Lasers Imaging · 2009Comparative Study, Research Support, Non-U.S. Gov't
- Cirrus HD-OCT short-term repeatability of clinical retinal nerve fiber layer measurements.
Wong E, Yoshioka N, Kalloniatis M, et al. · Optom Vis Sci · 2015Observational Study, Research Support, Non-U.S. Gov't
- Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes.
Manjunath V, Fujimoto JG, Duker JS · Retina · 2010Comment, Letter
- Influence of OSCAR-IB Criteria on Test-Retest Reliability of Cirrus HD-OCT Retinal Thickness Measurements in People With Multiple Sclerosis.
Bacchetti A, Lin TY, McCormack B, et al. · Neurol Neuroimmunol Neuroinflamm · 2025
- Central corneal thickness measurement with Cirrus HD-OCT and Topcon SP-3000P.
De Bernardo M, Salzano FA, Rosa N · J Optom · 2018Comment
- Ability of cirrus HD-OCT optic nerve head parameters to discriminate normal from glaucomatous eyes.
Mwanza JC, Oakley JD, Budenz DL, et al. · Ophthalmology · 2011Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Haab striae: Optical coherence tomographic analysis.
Benito-Pascual B, Pascual-Prieto J, Martínez-de-la-Casa JM, et al. · J Fr Ophtalmol · 2019Case Reports
- ZEISS Angioplexࡊ Spectral Domain Optical Coherence Tomography Angiography: Technical Aspects.
Rosenfeld PJ, Durbin MK, Roisman L, et al. · Dev Ophthalmol · 2016Research Support, Non-U.S. Gov't, Review
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
- iVueOptovue, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.